Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis.
Seventy white patients with a diagnosis of MS and typed for their HLA-A, B, C, and DR were studied. A clinical interview and a questionnaire were used to evaluate the presence of narcoleptic symptoms. The prevalence of sleep attacks, cataplexy, and sleep paralysis was significantly elevated among these patients. However, no difference was seen between DR2 and non-DR2 subjects with regard to the incidence of narcoleptic symptoms. Nine DR2 patients complaining of both sleep attacks and cataplexy were studied in the sleep laboratory for five consecutive naps, but no polygraphic evidence of narcolepsy was found.
D000328:Adult; D005260:Female; D006684:HLA-DR Antigens / Q000032:analysis; D015802:HLA-DR2 Antigen; D006801:Humans; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000150:complications* / Q000276:immunology; D009290:Narcolepsy / Q000150:complications* / Q000276:immunology; D012895:Sleep, REM; D011795:Surveys and Questionnaires
D006684:HLA-DR Antigens; D015802:HLA-DR2 Antigen